Hu-Yang C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, Valverde-Molina J. FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study. Arch Bronconeumol (Engl Ed). 2021 Apr 28:S0300-2896(21)00125-3. doi: 10.1016/j.arbres.2021.03.021. Online ahead of print. No abstract available. English, Spanish. PubMed PMID: 34001353.
AÑO: 2021; IF: 6.333
|
Chiang CY, Ellwood P, Ellwood E, Garcia-Marcos L, Masekela R, Asher I, Badellino H, Sanz AB, Douros K, El Sony A, Diaz CG, Rodriguez MA, Moreno-Salvador A, Perez-Martini LF, Filho NR, Shpakou A, Sulaimanov S, Tavakol M, Valverde-Molina J, Yousef AA, Pearce N; GAN COVID Study Group. Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network. Pediatr Allergy Immunol. 2022 Jan;33(1):e13709. doi: 10.1111/pai.13709. Epub 2021 Dec 11. PubMed PMID: 34856034.
AÑO: 2022; IF: 4.4
|
Castilla-Martinez M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, Cabrejos-Perotti S, Miralles-Lopez JC, Carbonell-Martinez A, Bravo-Gutierrez FJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Early Effectiveness of Dupilumab in Patients With Type 2 Severe Asthma: A Prospective Real-Life Study. J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):126-128. doi: 10.18176/jiaci.0872. Epub 2022 Nov 24. No abstract available. PubMed PMID: 36420744.
AÑO: 2023; IF: 6.1
|
Valverde-Molina J, Garcia-Marcos L. Microbiome and Asthma: Microbial Dysbiosis and the Origins, Phenotypes, Persistence, and Severity of Asthma. Nutrients. 2023 Jan 17;15(3):486. doi: 10.3390/nu15030486. PubMed PMID: 36771193; PubMed Central PMCID: PMC9921812.
AÑO: 2023; IF: 4.8
|
Miralles-Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, Flores-Martin I, Alemany-Frances ML, Pajaron-Fernandez MJ, Mora-Gonzalez A, Cabrejos-Perotti S, El-Molaka Z, Meseguer-Arce J, Aviles-Ingles MJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR Group. Analysis of response of severe eosinophilic asthmatic patients to benralizumab. Allergol Immunopathol (Madr). 2022 Nov 1;50(6):163-168. doi: 10.15586/aei.v50i6.704. eCollection 2022. PubMed PMID: 36335460.
AÑO: 2022; IF: 1.8
|